Quanterix Corp Reports Q3 2026 Revenue Growth Amid Year-over-Year Decline
Quanterix Corporation (QTRX) reported third-quarter 2026 revenue of $35.0 million, marking a 6.3% sequential increase driven by improvements across all product categories and technology platforms. However, total revenue saw a 13.1% decline compared to the $40.2 million reported in Q3 2025, largely due to the termination of a diagnostic program. The company showed signs of operational improvement with non-GAAP gross margins rising to 47.4% and a net loss narrowing by 35.6% year-over-year. Key growth drivers included LucentAD test volumes doubling sequentially and near-record spatial consumables revenue, though the pharmaceutical end market faced softness in the EMEA region.
Tickers: $QTRX